NEXT CRISPR: An enhanced CRISPR-based nucleic acid biosensing platform using extended crRNA
Authors:
- Uyanga GanbaatarUGUyanga Ganbaatar
- Changchun LiuCLChangchun Liu
- 30 June 2022
- journal article
- research article
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 369
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 CA214072)
- National Institutes of Health (R01 EB023607)
- National Institutes of Health (U01 CA269147)
This publication has 26 references indexed in Scilit:
- CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activityScience, 2018
- Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6Science, 2018
- Partial DNA-guided Cas9 enables genome editing with reduced off-target activityNature Chemical Biology, 2018
- Enhanced proofreading governs CRISPR–Cas9 targeting accuracyNature, 2017
- Nucleic acid detection with CRISPR-Cas13a/C2c2Science, 2017
- Recombinase Polymerase Amplification Compared to Real-Time Polymerase Chain Reaction Test for the Detection of Fasciola hepatica in Human StoolThe American Journal of Tropical Medicine and Hygiene, 2017
- Rationally engineered Cas9 nucleases with improved specificityScience, 2016
- Plasmid-Encoded Tetracycline Efflux Pump Protein Alters Bacterial Stress Responses and Ecological Fitness of Acinetobacter oleivoransPLOS ONE, 2014
- Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickasesGenome Research, 2013
- Human Papillomavirus DetectionAdvances in Anatomic Pathology, 2013